Dusseldorf - Delayed Quote EUR
Terns Pharmaceuticals Inc (430.DU)
2.5000
-0.0800
(-3.10%)
As of 4:00:10 PM GMT+2. Market Open.
Breakdown
12/31/2024
12/31/2023
12/31/2022
12/31/2021
Total Assets
363,929
268,517
287,026
168,070
Total Liabilities Net Minority Interest
18,059
13,150
10,083
7,767
Total Equity Gross Minority Interest
345,870
255,367
276,943
160,303
Total Capitalization
345,870
255,367
276,943
160,303
Common Stock Equity
345,870
255,367
276,943
160,303
Capital Lease Obligations
1,347
603
1,205
--
Net Tangible Assets
345,870
255,367
276,943
160,303
Working Capital
346,459
255,488
276,717
160,110
Invested Capital
345,870
255,367
276,943
160,303
Tangible Book Value
345,870
255,367
276,943
160,303
Total Debt
1,347
603
1,205
--
Share Issued
84,938.8550
64,576.7190
53,723.1710
25,269.2710
Ordinary Shares Number
84,938.8550
64,576.7190
53,723.1710
25,269.2710
12/31/2021 - 4/1/2021
Upgrade to begin using 40 years of financial statements and get so much more.
Perform in-depth fundamental analysis with decades of income statements, balance sheets, and cash flows — all exportable.
Upgrade